Millennium on the hunt for drug-development deals

06/2/2009 | Wall Street Journal, The

Biotech firm Millennium Pharmaceuticals is searching for small, single-product deals to expand its midstage and late-stage drug pipeline, CEO Deborah Dunsire said. The U.S. unit of Takeda Pharmaceuticals might also make larger deals in the $10 billion range, but Dunsire declined to name potential partners.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX